Robert W. Hesslein's Net Worth
$19.1 Million
Who is Robert W. Hesslein?
Robert W. Hesslein has an estimated net worth of $19.1 Million. This is based on reported shares across multiple companies, which include Voyager Therapeutics, Inc., and Foundation Medicine, Inc..
SEC CIK
Robert W. Hesslein's CIK is 0001585018
Past Insider Trading and Trends
2015 was Robert W. Hesslein's most active year for acquiring shares with 5 total transactions. Robert W. Hesslein's most active month to acquire stocks was the month of March. 2017 was Robert W. Hesslein's most active year for disposing of shares, totalling 12 transactions. Robert W. Hesslein's most active month to dispose stocks was the month of June. 2015 saw Robert W. Hesslein paying a total of $1,069,279.80 for 48,600 shares, this is the most they've acquired in one year. In 2018 Robert W. Hesslein cashed out on 131,537 shares for a total of $16,153,925.30, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $7.44
Senior VP & General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.14% | -4.41K |
$7.76 | -$34,221.60 | 102.2K |
Mar 20
| |||
Form 4
| -3.00% | -3.30K |
$7.45 | -$24,562.65 | 106.61K |
Scheduled
|
Feb 17
| ||
Form 4
| -2.54% | -2.87K |
$7.67 | -$21,997.56 | 109.91K |
Scheduled
|
Feb 13
| ||
Form 4
| -1.90% | -2.19K |
$9.85 | -$21,549.00 | 112.78K |
Scheduled
|
Jan 17
| ||
Form 4
| -2.37% | -2.79K |
$8.25 | -$22,984.50 | 114.96K |
Scheduled
|
Apr 4
| ||
Form 4
| -4.04% | -4.96K |
$8.29 | -$41,099.57 | 117.75K |
Scheduled
|
Mar 21
| ||
Form 4
| -3.23% | -4.10K |
$3.55 | -$14,555.00 | 122.7K |
Scheduled
|
Feb 17
| ||
Form 4
| -2.50% | -3.25K |
$3.36 | -$10,926.72 | 126.8K |
Scheduled
|
Feb 11
| ||
Form 4
| +18.17% | 20K |
—
|
—
| 130.06K |
Jan 13
| |||
Form 4
| +3.08% | 3.29K |
$4.95 | $16,295.40 | 110.06K |
Scheduled
|
Apr 5
| ||
Form 4
| +35.99% | 30K |
—
|
—
| 113.35K |
Mar 19
| |||
Form 4
| +68.90% | 34K |
—
|
—
| 83.35K |
Feb 16
| |||
Form 4
| -6.06% | -3.19K |
$7.55 | -$24,054.30 | 49.35K |
Scheduled
|
Feb 11
| ||
Form 4
| -5.56% | -3.09K |
$8.51 | -$26,304.41 | 52.53K |
Scheduled
|
Apr 3
| ||
Form 4
| +97.78% | 27.5K |
—
|
—
| 55.63K |
Feb 10
| |||
Form 4
|
∞
| 28.13K |
—
|
—
| 28.13K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Foundation Medicine, Inc. No price found
SVP and General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -105.20K |
$137.00 | -$14,412,811.00 |
0
|
Jul 31
| |||
Form 4
| -2.34% | -2.52K |
$136.66 | -$344,383.20 | 105.2K |
Jul 2
| |||
Form 4
| +9.54% | 9.38K |
$69.16 | $576,908.23 | 107.72K |
Apr 1 - Apr 2
| |||
Form 4
| -15.49% | -18.02K |
$64.30 | -$1,158,750.30 | 98.34K |
Scheduled
|
Jan 16
| ||
Form 4
| -1.58% | -1.86K |
$64.00 | -$119,296.00 | 116.36K |
Jan 2
| |||
Form 4
| -1.80% | -2.17K |
$38.80 | -$84,002.00 | 118.23K |
Oct 2
| |||
Form 4
| -4.04% | -5.07K |
$38.84 | -$196,918.80 | 120.39K |
Jul 6
| |||
Form 4
| +5.94% | 7.03K |
$5.15 | $36,195.52 | 125.46K |
Jun 8
| |||
Form 4
| -0.84% | -1.01K |
$33.87 | -$34,174.83 | 118.43K |
May 12
| |||
Form 4
| +15.88% | 16.37K |
$35.80 | $585,938.60 | 119.44K |
May 1
| |||
Form 4
| -1.18% | -1.23K |
$31.96 | -$39,406.68 | 103.07K |
Apr 3
| |||
Form 4
| -5.64% | -6.23K |
$31.67 | -$197,335.77 | 104.31K |
Mar 16
| |||
Form 4
| -4.06% | -4.68K |
$17.74 | -$83,053.70 | 110.54K |
Jan 3 - Jan 4
| |||
Form 4
| -1.05% | -1.22K |
$23.65 | -$28,853.00 | 115.22K |
Oct 4
| |||
Form 4
| +8.76% | 9.38K |
$5.15 | $48,255.36 | 116.44K |
Aug 9
| |||
Form 4
| -4.21% | -4.71K |
$17.62 | -$82,924.85 | 107.06K |
Jul 1 - Jul 5
| |||
Form 4
| +67.40% | 45K |
$18.25 | $821,250.00 | 111.77K |
Apr 1
| |||
Form 4
| +80.88% | 29.85K |
$32.74 | $977,419.96 | 66.77K |
Jul 15
| |||
Form 4
| +14.54% | 4.69K |
$5.15 | $24,124.40 | 36.91K |
Jul 8
| |||
Form 4/A
| -52.70% | -35.90K |
$50.00 | -$1,795,000.00 | 32.23K |
Apr 7
| |||
Form 4
| -51.41% | -35.02K |
$50.00 | -$1,751,000.00 | 33.1K |
Apr 7
| |||
Form 4
| -6.37% | -4.63K |
$47.24 | -$218,957.40 | 68.13K |
Mar 5
| |||
Form 4
| +21.01% | 12.63K |
$26.59 | -$1,114.96 | 72.76K |
Mar 2
| |||
Form 4
| -10.43% | -7.00K |
$52.11 | -$364,781.20 | 60.13K |
Scheduled
|
Jan 12
| ||
Form 4
| -5.62% | -4.00K |
$23.03 | -$92,131.60 | 67.13K |
Scheduled
|
Jan 8
| ||
Form 4
| -5.32% | -4.00K |
$23.18 | -$92,733.00 | 71.13K |
Scheduled
|
Oct 17
| ||
Form 4
| -5.06% | -4.00K |
$27.22 | -$108,894.80 | 75.13K |
Scheduled
|
Jul 8
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||